Custom RNA Products
Applied Biosystems™ Carrier RNA
Ambion™ Carrier RNA (1 mg/mL) is a component of all the MagMAX™ Isolation Kits that may be purchased separately.
Invitrogen™ GeneArt™ CRISPR Nuclease mRNA
Superior quality GeneArt CRISPR Nuclease mRNA is formulated to improve product performance.
Invitrogen™ TrueGuide™ sgRNA Positive Control, HPRT1 (human)
Used for the optimization of transfection and verification of editing efficiency in transfected cells.
MilliporeSigma™ Calbiochem™ HIV Reverse Transcriptase, Recombinant E. coli
Provides an efficient target for antiviral agents.
Invitrogen™ TrueGuide™ sgRNA Positive Control, AAVS1 (human)
Ready-to-use, synthetic gRNAs maximizes and simplifies the performance of genome editing experiments.
MilliporeSigma™ Upstate In Vivo Shape Reagent (Live Cell RNA Structure Analysis)
Ready to use RNase-free solution with low toxicity to use with live cells for determination of RNA structure
New England Biolabs, Inc. NEBNext® Ultra™ II Non-Directional RNA Second Strand Synthesis Module – 20 reactions
This module is part of the non-directional Ultra II RNA workflow, for Illumina- compatible non-strand-specific RNA library construction. This workflow is compatible with poly(A) mRNA isolation or ribosomal RNA depletion, and enables high yield preparation of high quality libraries from 5 ng – 1 µg total RNA.
- Designed for use in the NEBNext Ultra II non-directional RNA workflow
Perkin Elmer US LLC Directional IV Absolute Reflectance Accessory
Directional IV Absolute Reflectance Accessory
Medchemexpress LLC MicroRNA Inhibitor N 20nmol | 20nmol
MicroRNA Inhibitor Negative Control is a full-length nucleotide 2 -methoxy modified oligonucleotide and can be used as a negative control The sequence of MicroRNA Inhibitor Negative Control is derived from cel-mir-239b It has minimal sequence identity with miRNAs in human mouse and rat
Medchemexpress LLC hsa-miR-150-5p inhib 20nmol | 20nmol
hsa-miR-150-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs The miRNA inhibitors have full-length nucleotide 2 -methoxy modification The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes thereby inhibiting miRNAs from functioning